NCT02211950View on ClinicalTrials.gov

Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 44847

DRUG

Acarbose

OTHER

Japanese diet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY